These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 9495606)
41. A biomodal distribution of plasma HVA/MHPG in the psychoses. Ottong SE; Garver DL Psychiatry Res; 1997 Mar; 69(2-3):97-103. PubMed ID: 9109177 [TBL] [Abstract][Full Text] [Related]
42. Homovanillic acid in caudate and pre-frontal cortex following acute and chronic neuroleptic administration. Bowers MB; Hoffman FJ Psychopharmacology (Berl); 1986; 88(1):63-5. PubMed ID: 2868484 [TBL] [Abstract][Full Text] [Related]
43. Plasma homovanillic acid as a predictor of response to neuroleptics. Davila R; Manero E; Zumarraga M; Andia I; Schweitzer JW; Friedhoff AJ Arch Gen Psychiatry; 1988 Jun; 45(6):564-7. PubMed ID: 3377643 [TBL] [Abstract][Full Text] [Related]
44. Plasma homovanillic acid levels and subtyping of schizophrenia. Chang WH; Chen TY; Lee CF; Hung JC; Hu WH; Yeh EK Psychiatry Res; 1988 Mar; 23(3):239-44. PubMed ID: 3387499 [TBL] [Abstract][Full Text] [Related]
45. Homovanillic acid in the cerebrospinal fluid: patterns of response after four weeks of neuroleptic treatment. Sharma RP; Javaid JI; Janicak PG; Davis JM; Faull K Biol Psychiatry; 1993 Aug; 34(3):128-34. PubMed ID: 8104508 [TBL] [Abstract][Full Text] [Related]
46. Treatment of neuroleptic-resistant mania and schizoaffective disorders. De Beaurepaire R Am J Psychiatry; 1992 Nov; 149(11):1614-5. PubMed ID: 1357993 [No Abstract] [Full Text] [Related]
54. Biological correlates of the congruence and incongruence of psychotic symptoms in patients with type 1 bipolar disorder. Basterreche N; Dávila R; Zumárraga M; Arrúe A; González-Torres MA; Zamalloa MI; Anguiano JB; Guimón J Neuropsychobiology; 2008; 58(3-4):111-7. PubMed ID: 18997477 [TBL] [Abstract][Full Text] [Related]
55. Plasma homovanillic acid as an index of central dopaminergic activity: studies in schizophrenic patients. Pickar D; Breier A; Kelsoe J Ann N Y Acad Sci; 1988; 537():339-46. PubMed ID: 2904783 [TBL] [Abstract][Full Text] [Related]
56. Effectiveness of antipsychotic therapy in a naturalistic setting: a comparison between risperidone, perphenazine, and haloperidol. Coley KC; Carter CS; DaPos SV; Maxwell R; Wilson JW; Branch RA J Clin Psychiatry; 1999 Dec; 60(12):850-6. PubMed ID: 10665632 [TBL] [Abstract][Full Text] [Related]
57. Persistence of cyclicity of the plasma dopamine metabolite, homovanillic acid, in neuroleptic treated schizophrenic patients. Davila R; Zumarraga M; Andia I; Friedhoff AJ Life Sci; 1989; 44(16):1117-21. PubMed ID: 2565009 [TBL] [Abstract][Full Text] [Related]
58. Brain contribution to the haloperidol-induced increase in plasma homovanillic acid. Kendler KS; Heninger GR; Roth RH Eur J Pharmacol; 1981 May; 71(2-3):321-6. PubMed ID: 7250191 [TBL] [Abstract][Full Text] [Related]
59. Specificity of plasma HVA response to dexamethasone in psychotic depression. Wolkowitz OM; Doran A; Breier A; Roy A; Pickar D Psychiatry Res; 1989 Aug; 29(2):177-86. PubMed ID: 2798596 [TBL] [Abstract][Full Text] [Related]
60. Different patterns of longitudinal changes in plasma levels of catecholamine metabolites and brain-derived neurotrophic factor after administration of atypical antipsychotics in first episode untreated schizophrenic patients. Yoshimura R; Ueda N; Hori H; Ikenouchi-Sugita A; Umene-Nakano W; Nakamura J World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):256-61. PubMed ID: 20218790 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]